US2021130223A1PendingUtilityA1
Bioactive glass compositions and dentin hypersensitivity remediation
Est. expiryNov 28, 2037(~11.3 yrs left)· nominal 20-yr term from priority
A61K 6/20A61K 8/19A61K 6/77A61K 8/26C03C 3/064C03C 3/097A61K 6/836C03C 4/0021A61K 8/21A61K 8/25A61Q 11/00
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A dental formulation including: a bioactive glass composition as defined herein, in an effective amount; and a suitable carrier as defined herein, in an effective amount. Also disclosed is a method of making and using the dental formulation to treat, for example, dentin sensitivities.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A dental formulation comprising:
a bioactive glass composition in an effective amount comprising a source of:
2 to 70% B2O3,
2 to 16% Al2O3,
5 to 30% CaO,
1 to 6% P2O5,
1 to 20% Na2O, and
1 to 20% MgO, based on a 100 mol % total of the composition; and
a carrier, in an effective amount based on the combined weight of the bioactive glass and the carrier.
2 . The dental formulation of claim 1 , wherein:
the bioactive glass further comprises a source of from 5 to 50% SiO 2 , based on a 100 mol % total of the composition, and the carrier comprises a source of silica of from 1 to 25 wt % SiO 2 by super addition to the bioactive glass.
3 . The dental formulation of claim 1 , wherein the bioactive glass further comprises a source of from 1 to 20% K2O.
4 . The dental formulation of claim 1 , wherein the bioactive glass is essentially free of silica as a source of SiO 2 , and free of inorganic potassium salts as a source of K 2 O.
5 . The dental formulation of claim 1 , further comprising a source of fluoride ion in an amount of from 1 to 25 mol % by super addition to the composition.
6 . The dental formulation of claim 5 , wherein the source of fluoride ion is selected from NaF, SnF2, CaF2, or a combination thereof.
7 . The dental formulation of claim 1 , wherein the bioactive glass is essentially free of a source of fluoride ion.
8 . The dental formulation of claim 1 , wherein the bioactive glass composition in an effective amount is from 0.1 to 10 wt %, and the suitable carrier in an effective amount is from 90 to 99.9 wt %.
9 . The dental formulation of claim 1 , wherein the carrier comprises at least one of an abrasive, a humectant, a flavorant, a colorant, an antibacterial agent, a surfactant, a whitening agent, a binder, or a mixture thereof.
10 . The dental formulation of claim 1 , wherein the suitable carrier comprises one or more forms selected from: a gum, a paste, a powder, a toothpaste, a mouthwash, a poultice, a tea, a sucker, a spray, or a mixture thereof.
11 . The dental formulation of claim 1 , wherein the bioactive glass composition in an effective amount comprising a source of:
6 to 10% Al2O3, 15 to 25% CaO, 1.5 to 2% P2O5, 4 to 8% Na2O, 6 to 10% K2O, and 6 to 10% MgO, based on a 100 mol % total of the composition.
12 . The dental formulation of claim 1 , wherein the bioactive glass composition comprises:
40 to 60% B2O3, and 0 to 10% SiO2, based on a 100 mol % total of the composition.
13 . The dental formulation of claim 1 , wherein the bioactive glass composition comprises:
20 to 40% B2O3, and 10 to 30% SiO2, based on a 100 mol % total of the composition.
14 . The dental formulation of claim 1 , wherein the bioactive glass composition comprises:
5 to 20% B2O3, and 30 to 50% SiO2, based on a 100 mol % total of the composition.
15 . A method of treating dental hypersensitivity, comprising:
reacting a borate or borosilicate glass composition with mammalian saliva to form hydroxycarbonated apatite or fluorapatite on a dentin surface, a dentin tubule, or combination thereof.
16 . The method of claim 15 , wherein the borate or borosilicate glass composition comprises:
2 to 70% B2O3, 2 to 16% Al2O3, 5 to 30% CaO, 1 to 6% P2O5, 1 to 20% Na2O, and 1 to 20% MgO, based on a 100 mol % total of the composition.
17 . The method of claim 16 , wherein the borate or borosilicate glass composition in an effective amount comprising a source of:
6 to 10% Al2O3, 15 to 25% CaO, 1.5 to 2% P2O5, 4 to 8% Na2O, 6 to 10% K2O, and 6 to 10% MgO, based on a 100 mol % total of the composition.
18 . The method of claim 16 , wherein the borate or borosilicate glass composition comprises:
40 to 60% B2O3, and 0 to 10% SiO2, based on a 100 mol % total of the composition.
19 . The method of claim 16 , wherein the borate or borosilicate glass composition comprises:
20 to 40% B2O3, and 10 to 30% SiO2, based on a 100 mol % total of the composition.
20 . The method of claim 16 , wherein the borate or borosilicate glass composition comprises:
5 to 20% B2O3, and 30 to 50% SiO2, based on a 100 mol % total of the composition.
21 . The method of claim 16 , wherein the borate or borosilicate glass composition comprises:
a source of fluoride ion in an amount of from 1 to 25 mol % by super addition to the composition.Join the waitlist — get patent alerts
Track US2021130223A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.